CVI-VZV-001 / CHA Vaccine Institute - LARVOL DELTA

Lipo-pam™ adjuvanted herpes zoster vaccine induces potent gE-specific cellular and humoral immune responses. (PubMed, NPJ Vaccines) - "Shingrix is a recombinant zoster vaccine that is currently used to prevent HZ. At present, CVI-VZV-001 is undergoing phase I clinical trials. This study suggests that CVI-VZV-001 can be a potent candidate for the HZ vaccine with high immunogenicity and safety."

Journal • Herpes Zoster • Infectious Disease • Pain • Varicella Zoster • CD4